Literature DB >> 18809691

Medulloblastoma: new insights into biology and treatment.

B Pizer1, S Clifford.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18809691     DOI： 10.1136/adc.2007.136655

Source DB:  PubMed          Journal:  Arch Dis Child Educ Pract Ed        ISSN： 1743-0585            Impact factor:   1.309


× No keyword cloud information.
  12 in total

1.  Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.

Authors:  David W Ellison; Mehmet Kocak; James Dalton; Hisham Megahed; Meryl E Lusher; Sarra L Ryan; Wei Zhao; Sarah Leigh Nicholson; Roger E Taylor; Simon Bailey; Steven C Clifford
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

Review 2.  A contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma.

Authors:  N Ceren Sümer-Turanlıgil; Emel Öykü Cetin; Yiğit Uyanıkgil
Journal:  Childs Nerv Syst       Date:  2013-01-06       Impact factor: 1.475

3.  ASPM gene expression in medulloblastoma.

Authors:  Tânia M Vulcani-Freitas; Najsla Saba-Silva; Andréa Cappellano; Sérgio Cavalheiro; Sueli K N Marie; Sueli M Oba-Shinjo; Suzana M F Malheiros; Sílvia Regina Caminada de Toledo
Journal:  Childs Nerv Syst       Date:  2010-08-06       Impact factor: 1.475

4.  p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma.

Authors:  D Meley; D G Spiller; M R H White; H McDowell; B Pizer; V Sée
Journal:  Cell Death Dis       Date:  2010-05-13       Impact factor: 8.469

Review 5.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

6.  High-dose chemotherapy with reduced-dose craniospinal radiotherapy in children with newly diagnosed high-risk brain tumor.

Authors:  Nack-Gyun Chung
Journal:  Korean J Hematol       Date:  2010-09-30

7.  Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699.

Authors:  R A Daniel; A L Rozanska; E A Mulligan; Y Drew; H D Thomas; D J Castelbuono; Z Hostomsky; E R Plummer; D A Tweddle; A V Boddy; S C Clifford; N J Curtin
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

Review 8.  Hedgehog signalling pathway: carcinogenesis and targeted therapy.

Authors:  Abdolali Ebrahimi; Leila Larijani; Afshin Moradi; Mohamad Reza Ebrahimi
Journal:  Iran J Cancer Prev       Date:  2013

9.  Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.

Authors:  Yuan Lu; Sarra L Ryan; David J Elliott; Graham R Bignell; P Andrew Futreal; David W Ellison; Simon Bailey; Steven C Clifford
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

10.  Overcoming multiple drug resistance mechanisms in medulloblastoma.

Authors:  Ramadhan T Othman; Ioanna Kimishi; Tracey D Bradshaw; Lisa C D Storer; Andrey Korshunov; Stefan M Pfister; Richard G Grundy; Ian D Kerr; Beth Coyle
Journal:  Acta Neuropathol Commun       Date:  2014-05-30       Impact factor: 7.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.